Holen Sie sich die Stockscreener-App
85.89
5.24%
4.155
Schlusskurs vom Vortag:
$81.73
Offen:
$80.36
24-Stunden-Volumen:
343.35K
Relative Volume:
0.87
Marktkapitalisierung:
$1.43B
Einnahmen:
$5.93B
Nettoeinkommen (Verlust:
$-405.35M
KGV:
-3.5277
EPS:
-24.3461
Netto-Cashflow:
$-148.87M
1W Leistung:
+44.29%
1M Leistung:
+186.22%
6M Leistung:
+528.15%
1J Leistung:
+40.42%
1-Tages-Spanne:
$78.33
$90.48
1-Wochen-Bereich:
$57.47
$90.48
52-Wochen-Spanne:
$7.48
$90.48
Agilon Health Inc Stock (AGL) Company Profile
Firmenname
Agilon Health Inc
Sektor
Branche
Telefon
562-256-3800
Adresse
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
85.92 | 1.36B | 5.93B | -405.35M | -148.87M | -24.35 |
HCA
Hca Healthcare Inc
|
422.58 | 93.84B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
192.74 | 16.94B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
200.40 | 12.82B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
22.23 | 11.60B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
106.02 | 10.58B | 6.07B | 793.80M | 464.40M | 5.9914 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-25 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-04-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-01-10 | Eingeleitet | Needham | Hold |
| 2024-12-16 | Eingeleitet | Macquarie | Neutral |
| 2024-12-11 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-11-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-04-22 | Eingeleitet | Citigroup | Neutral |
| 2024-03-06 | Eingeleitet | Barclays | Underweight |
| 2024-02-26 | Herabstufung | Jefferies | Buy → Hold |
| 2024-02-26 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-05 | Herabstufung | Truist | Buy → Hold |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Eingeleitet | The Benchmark Company | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | In-line |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-09-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-09-12 | Eingeleitet | Goldman | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-06-24 | Eingeleitet | BTIG Research | Neutral |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-10-20 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-05-11 | Eingeleitet | William Blair | Outperform |
| 2021-05-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-10 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-10 | Eingeleitet | Goldman | Buy |
| 2021-05-10 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-10 | Eingeleitet | Truist | Buy |
| 2021-05-10 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-10 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Agilon Health Inc Aktie (AGL) Neueste Nachrichten
Truist reiterates Hold on agilon health stock with $67 target - Investing.com UK
Truist reiterates Hold on agilon health stock with $67 target By Investing.com - Investing.com Canada
What's going on with Agilon Health stock Friday? - MSN
Agilon Health Q1 2026 Results: Revenue Beat, EBITDA Surge, and Full-Year Outlook RaisedNews and Statistics - IndexBox
5 Revealing Analyst Questions From agilon health’s Q1 Earnings Call - Yahoo Finance
AGL Maintains Rating by Citigroup -- Price Target Raised to $80. - GuruFocus
Agilon Health Is Maintained at Neutral by Citigroup - Moomoo
Bernstein raises Agilon Health stock price target on improved results - Investing.com India
NYSE New 52-Week Highs And Lows - Moomoo
Citi Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $80 - Moomoo
Bernstein raises Agilon Health stock price target on improved results By Investing.com - Investing.com Nigeria
Agilon Health (AGL) price target increased by 50.63% to 30.22 - MSN
AGL Stock Price, Quote & Chart | AGILON HEALTH INC (NYSE:AGL) - ChartMill
AQR Holdings reports 974,897-share, 5.87% stake in agilon health (AGL) - Stock Titan
Agilon Health stock reaches 52-week high at 72.48 USD By Investing.com - Investing.com South Africa
Agilon Health stock reaches 52-week high at 72.48 USD - Investing.com
Goldman Sachs (NYSE: GS) discloses 1.02M-share, 6.1% stake in Agilon Health - Stock Titan
agilon health (AGL) Q1 2026 Earnings Transcript - AOL.com
A Look At Agilon Health (AGL) Valuation After Strong Q1 Profitability And Raised 2026 Sales Guidance - Yahoo Finance
Earnings call transcript: Agilon Health’s Q1 2026 EPS Surges Past Expectations - Investing.com Nigeria
Earnings call transcript: Agilon Health’s Q1 2026 EPS Surges Past Expectations By Investing.com - Investing.com South Africa
Why agilon health (AGL) Is Up 160.1% After Profit Jumps On Better Medical Margins And Guidance - Sahm
Agilon Health Company Profile & Introduction - Moomoo
Agilon Health | 3: Initial statement of beneficial ownership of securities- O'Rourke Timothy Patrick - Moomoo
agilon health (NYSE: AGL) CEO receives 320,000 stock-based awards - Stock Titan
agilon health (NYSE: AGL) CEO O'Rourke named in initial Form 3 - Stock Titan
Agilon Health Is Maintained at Hold by TD Cowen - Moomoo
$Agilon Health (AGL.US)$ - Moomoo
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Cuts Target Price to $55 - Moomoo
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Agilon (AGL) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $55 - Moomoo
Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL) and Argenx Se (ARGX) - The Globe and Mail
Investigation Alert: Long-Term Investors in agilon health, inc. (NYSE: AGL) should contact the Shareholders Foundation - openPR.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
Prologis To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday - Sahm
Agilon Health Operational Initiatives Begin Showing Results - Sahm
What's Going On With Agilon Health Stock Friday? - Benzinga
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $22 to $72 - Moomoo
Agilon Health (AGL) Receives a Sell from Bank of America Securities - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: Agilon Health (AGL) and REPRO-MED Systems (KRMD) - The Globe and Mail
Agilon Health soars after surpassing analyst Q1 expectations - Mugglehead Investment Magazine
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $22 to $49 - Moomoo
Agilon Health (AGL) Swings To Q1 Profit Challenging Longstanding Loss-Making Narrative - simplywall.st
Agilon Health Stock More Than Doubles After Q1 Beat. The Turnaround Test Starts Now - TechStock²
Finanzdaten der Agilon Health Inc-Aktie (AGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.51%
1.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):